The effervescent tablet market was valued at $8,281.52M in 2021 and is expected to reach $5557.08M by 2029, registering a CAGR of 8.20% during the forecast period of 2022 to 2029, according to a report by Data Bridge Market Research.
Many studies around the world have discovered that the most regularly administered product form, tablets, is perceived as a challenging process for a major portion of the population due to swallowing difficulties. The need to improve compliance has arisen due to the desire for dosage form optimization. Swallowing has been a key hurdle to tablet and capsule compliance, particularly among children and the elderly. To resolve this concern, pharmaceutical companies have developed many alternative user-friendly dosage forms, such as effervescent tablets.
Because of the rapid breakdown, the tablet dissolves into a frothy or fizzy solution. A variety of drugs can be administered using these pills. Using these tablets has a number of advantages. Because the medications are supplied in the form of a readily absorbed solution, one of the most significant advantages is that they quickly deliver pharmaceuticals to the body.